NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

糖尿病足部潰傷:全球臨床實驗趨勢(2021年前半期)

Diabetic Foot Ulcers - Global Clinical Trials Review, H1, 2021

出版商 GlobalData 商品編碼 1015591
出版日期 內容資訊 英文 275 Pages
訂單完成後即時交付
價格
糖尿病足部潰傷:全球臨床實驗趨勢(2021年前半期) Diabetic Foot Ulcers - Global Clinical Trials Review, H1, 2021
出版日期: 2021年06月17日內容資訊: 英文 275 Pages
簡介

本報告提供糖尿病足部潰傷臨床實驗相關的基本資料資料,先進7個國家(G7)及新興7個國家(E7)的實驗數量及受試者的募集情況,各階段趨勢,實施臨床實驗的主要的製藥企業及研究機關的簡介等彙整資訊。

目錄

  • 報告指南
  • 調查範圍
  • 各國臨床實驗數量
  • 實驗數量和平均實驗人數
  • 臨床實驗數量亞太地區的主要5個國家
  • 臨床實驗數量歐洲的主要5個國家
  • 北美的主要國家臨床實驗數量
  • 臨床實驗數量中東、非洲的主要5個國家
  • 臨床實驗數量中南美的主要5個國家
  • G7各國臨床實驗數量:代謝疾病臨床實驗中糖尿病足部潰傷的比例
  • G7各國臨床實驗數量:各階段
  • G7各國臨床實驗數量:各臨床實驗狀況
  • E7各國臨床實驗數量:代謝疾病臨床實驗中糖尿病足部潰傷的比例
  • E7各國臨床實驗數量:各階段
  • E7各國臨床實驗數量:各臨床實驗狀況
  • 臨床實驗數量:各階段
  • 進行中的實驗數量:各階段
  • 臨床實驗數量:各臨床實驗狀況
  • 臨床實驗數量:各端點狀況
  • 一定期間募集的受驗人數
  • 臨床實驗數量:各贊助商類型
  • 參加糖尿病足部潰傷治療藥臨床實驗的前幾名企業
  • 有前途的藥品
  • 臨床實驗的簡介

附錄

  • 簡稱
  • 定義
  • 調查手法
  • 2次調查
  • 關於GlobalData
  • 諮詢方式
  • 來源

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC6703CTIDB

GlobalData's clinical trial report, "Diabetic Foot Ulcers - Global Clinical Trials Review, H1, 2021" provides an overview of Diabetic Foot Ulcers Clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Foot Ulcers. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

List of Tables

List of Figures

  • Report Guidance
  • GlobalData Clinical Trials Report Coverage
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
  • Top Five Countries Contributing to Clinical Trials in Europe
  • Top Countries Contributing to Clinical Trials in North America
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
  • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Diabetic Foot Ulcers to Metabolic Disorders Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Diabetic Foot Ulcers to Metabolic Disorders Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
  • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Top Companies Participating in Diabetic Foot Ulcers Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots

Appendix

  • Abbreviations
  • Definitions
  • Research Methodology
  • Secondary Research
  • About GlobalData
  • Contact Us
  • Source

List of Tables

List of Tables

  • Diabetic Foot Ulcers Therapeutics, Global, Clinical Trials by Region, 2021*
  • Diabetic Foot Ulcers Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2021*
  • Diabetic Foot Ulcers Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2021*
  • Diabetic Foot Ulcers Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2021*
  • Diabetic Foot Ulcers Therapeutics Clinical Trials, Europe, Top Five Countries, 2021*
  • Diabetic Foot Ulcers Therapeutics Clinical Trials, North America, Top Countries, 2021*
  • Diabetic Foot Ulcers Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2021*
  • Diabetic Foot Ulcers Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2021*
  • Proportion of Diabetic Foot Ulcers to Metabolic Disorders Clinical Trials, G7 Countries (%), 2021*
  • Diabetic Foot Ulcers Therapeutics, G7 Countries, Clinical Trials by Phase, 2021*
  • Diabetic Foot Ulcers Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2021*
  • Proportion of Diabetic Foot Ulcers to Metabolic Disorders Clinical Trials, E7 Countries (%), 2021*
  • Diabetic Foot Ulcers Therapeutics, E7 Countries, Clinical Trials by Phase, 2021*
  • Diabetic Foot Ulcers Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2021*
  • Diabetic Foot Ulcers Therapeutics, Global, Clinical Trials by Phase, 2021*
  • Diabetic Foot Ulcers Therapeutics, Global, Clinical Trials In Progress by Phase 2021*
  • Diabetic Foot Ulcers Therapeutics, Global, Clinical Trials by Trial Status, 2021*
  • Diabetic Foot Ulcers Therapeutics Clinical Trials, Global, by End Point Status, 2021*
  • Diabetic Foot Ulcers Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2016-2020
  • Diabetic Foot Ulcers Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2021*
  • Diabetic Foot Ulcers Therapeutics Clinical Trials, Global, Key Sponsors, 2021*
  • Diabetic Foot Ulcers Therapeutics Clinical Trials, Global, Top Companies by Phase, 2021*
  • Diabetic Foot Ulcers Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2021*

List of Figures

List of Figures

  • Diabetic Foot Ulcers Therapeutics, Global, Clinical Trials by Region (%), 2021*
  • Diabetic Foot Ulcers Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2021*
  • Diabetic Foot Ulcers Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2021*
  • Diabetic Foot Ulcers Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2021*
  • Diabetic Foot Ulcers Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2021*
  • Diabetic Foot Ulcers Therapeutics Clinical Trials, North America, Top Countries (%), 2021*
  • Diabetic Foot Ulcers Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2021*
  • Diabetic Foot Ulcers Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2021*
  • Proportion of Diabetic Foot Ulcers to Metabolic Disorders Clinical Trials, G7 Countries (%), 2021*
  • Diabetic Foot Ulcers Therapeutics, G7 Countries, Clinical Trials by Phase, 2021*
  • Diabetic Foot Ulcers Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2021*
  • Proportion of Diabetic Foot Ulcers to Metabolic Disorders Clinical Trials, E7 Countries (%), 2021*
  • Diabetic Foot Ulcers Therapeutics, E7 Countries, Clinical Trials by Phase, 2021*
  • Diabetic Foot Ulcers Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2021*
  • Diabetic Foot Ulcers Therapeutics, Global, Clinical Trials by Phase (%), 2021*
  • Diabetic Foot Ulcers Therapeutics, Global, Clinical Trials In Progress by Phase, 2021*
  • Diabetic Foot Ulcers Therapeutics, Global, Clinical Trials by Trial Status, 2021*
  • Diabetic Foot Ulcers Therapeutics Clinical Trials, Global, by End Point Status, 2021*
  • Diabetic Foot Ulcers Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2016-2020
  • Diabetic Foot Ulcers Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2021*
  • Diabetic Foot Ulcers Therapeutics Clinical Trials, Global, Key Sponsors, 2021*
  • Diabetic Foot Ulcers Therapeutics Clinical Trials, Global, Top Companies by Phase, 2021*
  • Diabetic Foot Ulcers Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2021*
  • GlobalData Methodology